Global Cardiology Point-of-Care (POC) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Cardiology Point-of-Care (POC) Diagnostics market size was valued at USD 138.5 million in 2023 and is forecast to a readjusted size of USD 235 million by 2030 with a CAGR of 7.8% during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Cardiology Point-of-Care (POC) Diagnostics industry chain, the market status of Professional Diagnostic Centers (Cardiometabolic Monitoring, Cardiometabolic Diagnostics), Hospitals/Critical Care Centers (Cardiometabolic Monitoring, Cardiometabolic Diagnostics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cardiology Point-of-Care (POC) Diagnostics.

Regionally, the report analyzes the Cardiology Point-of-Care (POC) Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cardiology Point-of-Care (POC) Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cardiology Point-of-Care (POC) Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cardiology Point-of-Care (POC) Diagnostics industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cardiometabolic Monitoring, Cardiometabolic Diagnostics).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cardiology Point-of-Care (POC) Diagnostics market.

Regional Analysis: The report involves examining the Cardiology Point-of-Care (POC) Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cardiology Point-of-Care (POC) Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cardiology Point-of-Care (POC) Diagnostics:
Company Analysis: Report covers individual Cardiology Point-of-Care (POC) Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cardiology Point-of-Care (POC) Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Professional Diagnostic Centers, Hospitals/Critical Care Centers).

Technology Analysis: Report covers specific technologies relevant to Cardiology Point-of-Care (POC) Diagnostics. It assesses the current state, advancements, and potential future developments in Cardiology Point-of-Care (POC) Diagnostics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cardiology Point-of-Care (POC) Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cardiology Point-of-Care (POC) Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Cardiometabolic Monitoring
    Cardiometabolic Diagnostics

Market segment by Application
    Professional Diagnostic Centers
    Hospitals/Critical Care Centers
    Research Laboratories
    Home Care

Market segment by players, this report covers
    Siemens
    Abbott
    Roche
    Opko
    GE Healthcare
    Samsung Health
    BioMerieux
    Abbott
    Terumo
    Accriva
    Akers
    Radiometer
    Response Biomedical

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cardiology Point-of-Care (POC) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cardiology Point-of-Care (POC) Diagnostics, with revenue, gross margin and global market share of Cardiology Point-of-Care (POC) Diagnostics from 2019 to 2024.
Chapter 3, the Cardiology Point-of-Care (POC) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cardiology Point-of-Care (POC) Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cardiology Point-of-Care (POC) Diagnostics.
Chapter 13, to describe Cardiology Point-of-Care (POC) Diagnostics research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cardiology Point-of-Care (POC) Diagnostics
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cardiology Point-of-Care (POC) Diagnostics by Type
        1.3.1 Overview: Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type in 2023
        1.3.3 Cardiometabolic Monitoring
        1.3.4 Cardiometabolic Diagnostics
    1.4 Global Cardiology Point-of-Care (POC) Diagnostics Market by Application
        1.4.1 Overview: Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Professional Diagnostic Centers
        1.4.3 Hospitals/Critical Care Centers
        1.4.4 Research Laboratories
        1.4.5 Home Care
    1.5 Global Cardiology Point-of-Care (POC) Diagnostics Market Size & Forecast
    1.6 Global Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast by Region
        1.6.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Region, (2019-2030)
        1.6.3 North America Cardiology Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)
        1.6.4 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)
        1.6.6 South America Cardiology Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Cardiology Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Siemens
        2.1.1 Siemens Details
        2.1.2 Siemens Major Business
        2.1.3 Siemens Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.1.4 Siemens Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Siemens Recent Developments and Future Plans
    2.2 Abbott
        2.2.1 Abbott Details
        2.2.2 Abbott Major Business
        2.2.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.2.4 Abbott Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Abbott Recent Developments and Future Plans
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.3.4 Roche Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Roche Recent Developments and Future Plans
    2.4 Opko
        2.4.1 Opko Details
        2.4.2 Opko Major Business
        2.4.3 Opko Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.4.4 Opko Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Opko Recent Developments and Future Plans
    2.5 GE Healthcare
        2.5.1 GE Healthcare Details
        2.5.2 GE Healthcare Major Business
        2.5.3 GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.5.4 GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 GE Healthcare Recent Developments and Future Plans
    2.6 Samsung Health
        2.6.1 Samsung Health Details
        2.6.2 Samsung Health Major Business
        2.6.3 Samsung Health Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.6.4 Samsung Health Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Samsung Health Recent Developments and Future Plans
    2.7 BioMerieux
        2.7.1 BioMerieux Details
        2.7.2 BioMerieux Major Business
        2.7.3 BioMerieux Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.7.4 BioMerieux Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 BioMerieux Recent Developments and Future Plans
    2.8 Abbott
        2.8.1 Abbott Details
        2.8.2 Abbott Major Business
        2.8.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.8.4 Abbott Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Abbott Recent Developments and Future Plans
    2.9 Terumo
        2.9.1 Terumo Details
        2.9.2 Terumo Major Business
        2.9.3 Terumo Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.9.4 Terumo Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Terumo Recent Developments and Future Plans
    2.10 Accriva
        2.10.1 Accriva Details
        2.10.2 Accriva Major Business
        2.10.3 Accriva Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.10.4 Accriva Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Accriva Recent Developments and Future Plans
    2.11 Akers
        2.11.1 Akers Details
        2.11.2 Akers Major Business
        2.11.3 Akers Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.11.4 Akers Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Akers Recent Developments and Future Plans
    2.12 Radiometer
        2.12.1 Radiometer Details
        2.12.2 Radiometer Major Business
        2.12.3 Radiometer Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.12.4 Radiometer Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Radiometer Recent Developments and Future Plans
    2.13 Response Biomedical
        2.13.1 Response Biomedical Details
        2.13.2 Response Biomedical Major Business
        2.13.3 Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
        2.13.4 Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Response Biomedical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cardiology Point-of-Care (POC) Diagnostics Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Cardiology Point-of-Care (POC) Diagnostics by Company Revenue
        3.2.2 Top 3 Cardiology Point-of-Care (POC) Diagnostics Players Market Share in 2023
        3.2.3 Top 6 Cardiology Point-of-Care (POC) Diagnostics Players Market Share in 2023
    3.3 Cardiology Point-of-Care (POC) Diagnostics Market: Overall Company Footprint Analysis
        3.3.1 Cardiology Point-of-Care (POC) Diagnostics Market: Region Footprint
        3.3.2 Cardiology Point-of-Care (POC) Diagnostics Market: Company Product Type Footprint
        3.3.3 Cardiology Point-of-Care (POC) Diagnostics Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Cardiology Point-of-Care (POC) Diagnostics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2024)
    5.2 Global Cardiology Point-of-Care (POC) Diagnostics Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    6.2 North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    6.3 North America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country
        6.3.1 North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2030)
        6.3.2 United States Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        6.3.3 Canada Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        6.3.4 Mexico Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    7.2 Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    7.3 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size by Country
        7.3.1 Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2030)
        7.3.2 Germany Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        7.3.3 France Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        7.3.5 Russia Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        7.3.6 Italy Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Region (2019-2030)
        8.3.2 China Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.3 Japan Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.4 South Korea Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.5 India Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.7 Australia Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    9.2 South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    9.3 South America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country
        9.3.1 South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2030)
        9.3.2 Brazil Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        9.3.3 Argentina Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2030)
        10.3.2 Turkey Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        10.3.4 UAE Cardiology Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Cardiology Point-of-Care (POC) Diagnostics Market Drivers
    11.2 Cardiology Point-of-Care (POC) Diagnostics Market Restraints
    11.3 Cardiology Point-of-Care (POC) Diagnostics Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Cardiology Point-of-Care (POC) Diagnostics Industry Chain
    12.2 Cardiology Point-of-Care (POC) Diagnostics Upstream Analysis
    12.3 Cardiology Point-of-Care (POC) Diagnostics Midstream Analysis
    12.4 Cardiology Point-of-Care (POC) Diagnostics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Siemens Company Information, Head Office, and Major Competitors
    Table 6. Siemens Major Business
    Table 7. Siemens Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 8. Siemens Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Siemens Recent Developments and Future Plans
    Table 10. Abbott Company Information, Head Office, and Major Competitors
    Table 11. Abbott Major Business
    Table 12. Abbott Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 13. Abbott Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Abbott Recent Developments and Future Plans
    Table 15. Roche Company Information, Head Office, and Major Competitors
    Table 16. Roche Major Business
    Table 17. Roche Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 18. Roche Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Roche Recent Developments and Future Plans
    Table 20. Opko Company Information, Head Office, and Major Competitors
    Table 21. Opko Major Business
    Table 22. Opko Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 23. Opko Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Opko Recent Developments and Future Plans
    Table 25. GE Healthcare Company Information, Head Office, and Major Competitors
    Table 26. GE Healthcare Major Business
    Table 27. GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 28. GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. GE Healthcare Recent Developments and Future Plans
    Table 30. Samsung Health Company Information, Head Office, and Major Competitors
    Table 31. Samsung Health Major Business
    Table 32. Samsung Health Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 33. Samsung Health Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Samsung Health Recent Developments and Future Plans
    Table 35. BioMerieux Company Information, Head Office, and Major Competitors
    Table 36. BioMerieux Major Business
    Table 37. BioMerieux Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 38. BioMerieux Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. BioMerieux Recent Developments and Future Plans
    Table 40. Abbott Company Information, Head Office, and Major Competitors
    Table 41. Abbott Major Business
    Table 42. Abbott Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 43. Abbott Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Abbott Recent Developments and Future Plans
    Table 45. Terumo Company Information, Head Office, and Major Competitors
    Table 46. Terumo Major Business
    Table 47. Terumo Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 48. Terumo Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Terumo Recent Developments and Future Plans
    Table 50. Accriva Company Information, Head Office, and Major Competitors
    Table 51. Accriva Major Business
    Table 52. Accriva Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 53. Accriva Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Accriva Recent Developments and Future Plans
    Table 55. Akers Company Information, Head Office, and Major Competitors
    Table 56. Akers Major Business
    Table 57. Akers Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 58. Akers Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Akers Recent Developments and Future Plans
    Table 60. Radiometer Company Information, Head Office, and Major Competitors
    Table 61. Radiometer Major Business
    Table 62. Radiometer Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 63. Radiometer Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Radiometer Recent Developments and Future Plans
    Table 65. Response Biomedical Company Information, Head Office, and Major Competitors
    Table 66. Response Biomedical Major Business
    Table 67. Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Product and Solutions
    Table 68. Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Response Biomedical Recent Developments and Future Plans
    Table 70. Global Cardiology Point-of-Care (POC) Diagnostics Revenue (USD Million) by Players (2019-2024)
    Table 71. Global Cardiology Point-of-Care (POC) Diagnostics Revenue Share by Players (2019-2024)
    Table 72. Breakdown of Cardiology Point-of-Care (POC) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Cardiology Point-of-Care (POC) Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 74. Head Office of Key Cardiology Point-of-Care (POC) Diagnostics Players
    Table 75. Cardiology Point-of-Care (POC) Diagnostics Market: Company Product Type Footprint
    Table 76. Cardiology Point-of-Care (POC) Diagnostics Market: Company Product Application Footprint
    Table 77. Cardiology Point-of-Care (POC) Diagnostics New Market Entrants and Barriers to Market Entry
    Table 78. Cardiology Point-of-Care (POC) Diagnostics Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value (USD Million) by Type (2019-2024)
    Table 80. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Share by Type (2019-2024)
    Table 81. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Forecast by Type (2025-2030)
    Table 82. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024)
    Table 83. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Forecast by Application (2025-2030)
    Table 84. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 85. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 86. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 87. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 88. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 89. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 90. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 91. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 92. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 93. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 94. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 95. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 96. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 97. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 98. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 99. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 100. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
    Table 101. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
    Table 102. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 103. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 104. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 105. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 106. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 107. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 108. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 110. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 111. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 112. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 113. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 114. Cardiology Point-of-Care (POC) Diagnostics Raw Material
    Table 115. Key Suppliers of Cardiology Point-of-Care (POC) Diagnostics Raw Materials
List of Figures
    Figure 1. Cardiology Point-of-Care (POC) Diagnostics Picture
    Figure 2. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type in 2023
    Figure 4. Cardiometabolic Monitoring
    Figure 5. Cardiometabolic Diagnostics
    Figure 6. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application in 2023
    Figure 8. Professional Diagnostic Centers Picture
    Figure 9. Hospitals/Critical Care Centers Picture
    Figure 10. Research Laboratories Picture
    Figure 11. Home Care Picture
    Figure 12. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Market Cardiology Point-of-Care (POC) Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 15. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Region (2019-2030)
    Figure 16. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Region in 2023
    Figure 17. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 18. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 19. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 20. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 21. Middle East and Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 22. Global Cardiology Point-of-Care (POC) Diagnostics Revenue Share by Players in 2023
    Figure 23. Cardiology Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 24. Global Top 3 Players Cardiology Point-of-Care (POC) Diagnostics Market Share in 2023
    Figure 25. Global Top 6 Players Cardiology Point-of-Care (POC) Diagnostics Market Share in 2023
    Figure 26. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Share by Type (2019-2024)
    Figure 27. Global Cardiology Point-of-Care (POC) Diagnostics Market Share Forecast by Type (2025-2030)
    Figure 28. Global Cardiology Point-of-Care (POC) Diagnostics Consumption Value Share by Application (2019-2024)
    Figure 29. Global Cardiology Point-of-Care (POC) Diagnostics Market Share Forecast by Application (2025-2030)
    Figure 30. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 31. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 32. North America Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 33. United States Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 34. Canada Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 35. Mexico Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 36. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 37. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 38. Europe Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 39. Germany Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 40. France Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 41. United Kingdom Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 42. Russia Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 43. Italy Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 44. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 45. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 46. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Region (2019-2030)
    Figure 47. China Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 48. Japan Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 49. South Korea Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 50. India Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 51. Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 52. Australia Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 53. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 54. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 55. South America Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 56. Brazil Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 57. Argentina Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 58. Middle East and Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 59. Middle East and Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 60. Middle East and Africa Cardiology Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 61. Turkey Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 62. Saudi Arabia Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 63. UAE Cardiology Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 64. Cardiology Point-of-Care (POC) Diagnostics Market Drivers
    Figure 65. Cardiology Point-of-Care (POC) Diagnostics Market Restraints
    Figure 66. Cardiology Point-of-Care (POC) Diagnostics Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Cardiology Point-of-Care (POC) Diagnostics in 2023
    Figure 69. Manufacturing Process Analysis of Cardiology Point-of-Care (POC) Diagnostics
    Figure 70. Cardiology Point-of-Care (POC) Diagnostics Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Companies Mentioned

Siemens
Abbott
Roche
Opko
GE Healthcare
Samsung Health
BioMerieux
Abbott
Terumo
Accriva
Akers
Radiometer
Response Biomedical